{
    "clinical_study": {
        "@rank": "117876", 
        "brief_summary": {
            "textblock": "The purpose of this study is to see if it is safe and effective to give Viracept to AIDS\n      patients who are being treated for MAC."
        }, 
        "brief_title": "A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC)", 
        "condition": [
            "Mycobacterium Avium-Intracellulare Infection", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome", 
                "Mycobacterium Infections", 
                "Mycobacterium avium-intracellulare Infection", 
                "Opportunistic Infections"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  HIV infection\n\n          -  New diagnosis of MAC bacteremia and < 7 days of therapy.\n\n        Prior Medication:\n\n        Allowed:\n\n        Patients no more than 7 days of therapy for MAC disease.\n\n        Exclusion Criteria\n\n        Prior Medication:\n\n        Excluded:\n\n        Prior therapy (or less than 2 weeks) with protease inhibitors other than saquinavir."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "13 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002170", 
            "org_study_id": "259C", 
            "secondary_id": [
                "Study 518", 
                "AG1343-518"
            ]
        }, 
        "intervention": {
            "intervention_name": "Nelfinavir mesylate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Infective Agents", 
                "Nelfinavir", 
                "HIV Protease Inhibitors"
            ]
        }, 
        "keyword": [
            "AIDS-Related Opportunistic Infections", 
            "Placebos", 
            "Mycobacterium avium-intracellulare Infection", 
            "Acquired Immunodeficiency Syndrome", 
            "HIV Protease Inhibitors", 
            "Nelfinavir", 
            "Anti-Infective Agents", 
            "Anti-HIV Agents"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92103"
                    }, 
                    "name": "Univ of California / San Diego Treatment Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Torrance", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90502"
                    }, 
                    "name": "Harbor UCLA Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60612"
                    }, 
                    "name": "Rush Presbyterian - Saint Luke's Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02730"
                    }, 
                    "name": "Boston VA Med Ctr / 151"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77009"
                    }, 
                    "name": "Baylor Univ"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Pilot, Phase II, Randomized, Placebo-Controlled Study to Determine the Effects of Viracept on the Clinical Outcome of Disseminated Mycobacterium Avium Complex Disease (MAC) in AIDS Patients Who Are Receiving Standard Acute Treatment for This Opportunistic Infection", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002170"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Agouron Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 1999"
    }, 
    "geocoordinates": {
        "Baylor Univ": "29.76 -95.369", 
        "Boston VA Med Ctr / 151": "42.358 -71.06", 
        "Harbor UCLA Med Ctr": "33.836 -118.341", 
        "Rush Presbyterian - Saint Luke's Med Ctr": "41.878 -87.63", 
        "Univ of California / San Diego Treatment Ctr": "32.715 -117.157"
    }
}